Search

Author/Creator Ding, Linna

1. 178 Phase 2 trial of induction therapy with anti-CD20 (Rituximab) followed by maintenance therapy with anti-BAFF (Belimumab) in patients with active lupus nephritis. (April 2019)

Authors:
Aranow, Cynthia; DallEra, Maria C; Byron, Margaret; Ding, Linna; Smilek, Dawn; Diamond, Betty; Wofsy, David
Journal:
Lupus science & medicine
Issue:
Volume 6(2019)supplement 1
Page Start:
A136
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type. Issue 6 (30th November 2015)

Authors:
Unizony, Sebastian; Villarreal, Miguel; Miloslavsky, Eli M; Lu, Na; Merkel, Peter A; Spiera, Robert; Seo, Philip; Langford, Carol A; Hoffman, Gary S; Kallenberg, CG M; St. Clair, E William; Ikle, David; Tchao, Nadia K; Ding, Linna; Brunetta, Paul; Choi, Hyon K; Monach, Paul A; Fervenza, Fernando;...
Journal:
Annals of the rheumatic diseases
Issue:
Volume 75:Issue 6(2016)
Page Start:
1166
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. CT-02 Features of patients screened for calibrate (rituximab plus cyclophosphamide followed by belimumab for the treatment of lupus nephritis); hypogammaglobulinemia is frequent in patients with marked elevation of urinary protein. (31st August 2016)

Authors:
Aranow, Cynthia; Diamond, Betty; Wofsy, David; Byron, Margaret; Smilek, Dawn; Ding, Linna; Tosta, Patti; Ryker, Kristin; Gao, Wendy; Dall'Era, Maria
Journal:
Lupus science & medicine
Issue:
Volume 3(2016)Supplement 1
Page Start:
A38
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. CT-03 Phase 2 trial of induction therapy with anti-CD20 (rituximab) followed by maintenance therapy with anti-BAFF (belimumab) in patients with active lupus nephritis. (August 2018)

Authors:
Aranow, Cynthia; Dall'Era, Maria; Byron, Margie; Ding, Linna; Smilek, Dawn; Diamond, Betty; Wofsy, David
Journal:
Lupus science & medicine
Issue:
Volume 5(2018)Supplement 2
Page Start:
A46
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis. Issue 1 (1st December 2020)

Authors:
Atisha‐Fregoso, Yemil; Malkiel, Susan; Harris, Kristina M.; Byron, Margie; Ding, Linna; Kanaparthi, Sai; Barry, William T.; Gao, Wendy; Ryker, Kristin; Tosta, Patti; Askanase, Anca D.; Boackle, Susan A.; Chatham, W. Winn; Kamen, Diane L.; Karp, David R.; Kirou, Kyriakos A.; Sam Lim, S.; Marder, B...
Journal:
Arthritis & rheumatology
Issue:
Volume 73:Issue 1(2021)
Page Start:
121
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Serum proteins reflecting inflammation, injury and repair as biomarkers of disease activity in ANCA-associated vasculitis. Issue 8 (12th September 2012)

Authors:
Monach, Paul A; Warner, Roscoe L; Tomasson, Gunnar; Specks, Ulrich; Stone, John H; Ding, Linna; Fervenza, Fernando C; Fessler, Barri J; Hoffman, Gary S; Iklé, David; Kallenberg, Cees GM; Krischer, Jeffrey; Langford, Carol A; Mueller, Mark; Seo, Philip; St. Clair, E William; Spiera, Robert; Tchao,...
Journal:
Annals of the rheumatic diseases
Issue:
Volume 72:Issue 8(2013)
Page Start:
1342
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗